跳至主要内容
临床试验/NCT04125186
NCT04125186已完成不适用

Epidemiology and Burden of Nocturia Due to Nocturnal Polyuria in the United States: The EpiNP Study

Ferring Pharmaceuticals1 个研究点 分布在 1 个国家目标入组 10,190 人开始时间: 2019年7月22日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
10,190
试验地点
1
主要终点
To describe and compare demographic and clinical characteristics in participants with nocturia due to NP, NP with OAB, NP with BPH, and NP with BPH/OAB

研究概览

简要总结

To estimate the prevalence of nocturia due to nocturnal polyuria (NP) in the US and describe the demographic and clinical characteristics as well as the burden of illness in participants with nocturia due to NP.

研究设计

研究类型
Observational
观察模型
Other
时间视角
Cross Sectional

入排标准

年龄范围
30 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • At least 30 years of age;
  • Willing to provide informed consent;
  • Able to read US-English or Spanish
  • Able to use a computer and access the internet.

排除标准

  • Symptomatic acute urinary tract infection (UTI) (experiencing symptoms such as pain or burning when you urinate, strong and frequent urge to urinate, or cloudy, bloody, or strong-smelling urine);
  • Currently pregnant or ≤12 months postpartum;
  • Recent surgery in the last <6 months;
  • Current lifestyle that leads to irregular or atypical circadian patterns (e.g. employed in overnight shift work)
  • Prior YouGov survey participation in past two weeks

结局指标

主要结局

To describe and compare demographic and clinical characteristics in participants with nocturia due to NP, NP with OAB, NP with BPH, and NP with BPH/OAB

时间窗: Between July 2019 and June 2020

To describe and compare burden of illness in participants with nocturia due to NP, NP with OAB, NP with BPH, and NP with BPH/OAB

时间窗: Between July 2019 and June 2020

The burden measures (including health-related quality of life \[HRQL\], work productivity, fatigue, sleep, and depression as assessed through EpiNP survey and bladder diary) in participants with nocturia due to NP, NP with OAB, NP with BPH, and NP with BPH/OAB (overall and by relevant strata \[e.g., by age/race/gender categories\]) will be presented.

Prevalence of nocturia due to NP, NP with overactive bladder (OAB), NP with benign prostatic hyperplasia (BPH), and NP with BPH/OAB

时间窗: Between July 2019 and June 2020

Nocturia due to NP will be derived using data of participants who completed the 3-day bladder diaries. Nocturnal polyuria was defined when nocturnal urine production proportional to daytime urine production was greater than threshold 0.33 (Nocturnal Polyuria index \[NPi\]). Prevalence will be calculated using number of participants with nocturia due to NP, in the numerator (overall and by relevant strata \[e.g., by age/race/gender categories\]), with publicly-available estimates of the US population in the denominator (overall and for relevant strata). In addition, the prevalence of NP with OAB, NP with BPH, and NP with BPH/OAB will also be estimated.

次要结局

  • Prevalence of nocturia due to NP across the subgroups of respondents(Between July 2019 and June 2020)
  • To describe and compare demographic and clinical characteristics in participants with nocturia due to NP across the subgroups of respondents(Between July 2019 and June 2020)
  • To describe and compare burden of illness in participants with nocturia due to NP across the subgroups of respondents(Between July 2019 and June 2020)

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验